ISS ISE Services

ISS ISE Services

Quanticate has produced Integrated Summaries studies for various clients over the years. As a data focused CRO, Quanticate has the programmers and statisticians who can provide expert advice on combining of data for an ISS or ISE, including help in identifying how time to approval can be reduced by careful up-front planning. An ISS or ISE can be an important tool as a larger sample size of data allows for easier identification of any correlations and trends. This allows for better-presented and unbiased data for regulatory submissions as the regulatory authorities state ISE and ISS are critical components of a submission. Support in ISS/ISE preparation can be provided by our medical writing department.

Within Integrated Summaries of Safety (ISS), we can pool the safety results of different studies on the same compound together. Advantages of an ISS include:

  • Identification of common related AEs
  • Identification of common serious adverse events (SAEs)
  • Identification of safety concerns that may not be apparent from a single study
  • Allowing an assessment of safety in subgroups if sample sizes are sufficiently large.

Within Integrated Summaries of Effectiveness (ISE) we combine the efficacy results from different studies conducted on the same compound. The increased advantages of ISE can:

  • Enable the assessment of efficacy in subgroups (e.g. paediatrics)
  • Enable the assessment of the efficacy of secondary endpoints, which may have been under-powered in individual studies
  • Allow detailed comparison of results versus a comparator drug
  • Allow assessment of the efficacy of repeat doses
  • Enable the dose-response profile to be more accurately estimated
  • Allow any changes that may have occurred in efficacy over the lifetime of the drug development to be investigated
  • Help to address why results for a particular study may be inconsistent with the results of other studies
  • Enable the assessment of the sensitivity of results to different methodologies for defining endpoints, or different methodologies for handling missing data
issise-med-writing2
integrated-sumamries-iss-ise-cta
 

Thanks again for taking the role for DMC unblinded programming. Your strong support made sure this first DMC was done well. Thank you again for successfully managing these deliverables on time. Very nice job!

Clinical Programming 11

Contact Us

Contact Us

First Name *
Last Name *
Company *
Please check this box if you require support for your clinical trial.
Email *
Description

Phone Numbers

Europe

Telephone: +44 1462 440 084
Fax: +44 1462 440 086

United States

Telephone: +1 617 973 5119
Fax: +1 617 973 6406